Reuters logo
BRIEF-Shire granted EU approval for pancreatic cancer combination therapy
2016年10月18日 / 早上6点26分 / 1 年前

BRIEF-Shire granted EU approval for pancreatic cancer combination therapy

Oct 18 (Reuters) - Shire Plc

* Granted eu marketing authorization of onivyde, in combination with 5-fluorouracil (5-fu) and leucovorin (lv),for treatment of metastatic adenocarcinoma of pancreas in adult patients who have progressed following gemcitabine-based therapy Source text for Eikon: Further company coverage: (Reporting By UK Bureau)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below